- Home
- EMF vs INGN Comparison
EMF vs INGN Comparison
Compare EMF & INGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EMF
- INGN
- Stock Information
- Founded
- EMF 1987
- INGN 2001
- Country
- EMF United States
- INGN United States
- Employees
- EMF N/A
- INGN N/A
- Industry
- EMF Finance/Investors Services
- INGN Industrial Specialties
- Sector
- EMF Finance
- INGN Health Care
- Exchange
- EMF Nasdaq
- INGN Nasdaq
- Market Cap
- EMF 219.3M
- INGN 182.8M
- IPO Year
- EMF N/A
- INGN 2014
- Fundamental
- Price
- EMF $15.48
- INGN $7.46
- Analyst Decision
- EMF
- INGN Strong Buy
- Analyst Count
- EMF 0
- INGN 3
- Target Price
- EMF N/A
- INGN $11.00
- AVG Volume (30 Days)
- EMF 29.3K
- INGN 285.3K
- Earning Date
- EMF 01-01-0001
- INGN 08-07-2025
- Dividend Yield
- EMF 6.16%
- INGN N/A
- EPS Growth
- EMF N/A
- INGN N/A
- EPS
- EMF N/A
- INGN N/A
- Revenue
- EMF N/A
- INGN $343,472,000.00
- Revenue This Year
- EMF N/A
- INGN $7.47
- Revenue Next Year
- EMF N/A
- INGN $6.22
- P/E Ratio
- EMF N/A
- INGN N/A
- Revenue Growth
- EMF N/A
- INGN 5.15
- 52 Week Low
- EMF $10.58
- INGN $5.70
- 52 Week High
- EMF $12.67
- INGN $13.33
- Technical
- Relative Strength Index (RSI)
- EMF 67.87
- INGN 60.48
- Support Level
- EMF $14.83
- INGN $7.35
- Resistance Level
- EMF $15.54
- INGN $7.85
- Average True Range (ATR)
- EMF 0.20
- INGN 0.44
- MACD
- EMF 0.02
- INGN 0.15
- Stochastic Oscillator
- EMF 95.83
- INGN 80.50
About EMF Templeton Emerging Markets Fund
Templeton Emerging Markets Fund is a closed-end management investment company. It seeks long-term capital appreciation by investing, under normal market conditions, at least 80% of its net assets in emerging country equity securities. It invests in various sectors such as Pharmaceuticals, Beverages, Broadline Retail, Metals &Mining, Banks, Food Products, Semiconductors & Semiconductor Equipment, insurance, Entertainment, and others.
About INGN Inogen Inc
Inogen Inc is a medical technology company that develops and manufactures portable oxygen concentrators used to deliver oxygen therapy to patients with chronic respiratory conditions. Its key product, the Inogen One system, is a lightweight alternative to traditional, stationary oxygen concentrator systems and oxygen tanks. The firm sells its products to home medical equipment providers and also rents products directly to patients. Internationally, It sells its products through distributors large gas companies, and home oxygen providers. It generates the majority of its revenue in the United States.